SCHEMBL498121

SCHEMBL498121

CCCCN(C)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492545 0.92 DNM1 (0.46)
SCHEMBL16658724 0.90 DNM1 (0.50)
SCHEMBL18660081 0.90 DNM1 (0.50)
SCHEMBL4601205 0.90 DNM1 (0.50)
SCHEMBL1902069 0.90 DNM1 (0.50)
SCHEMBL6949703 0.90 DNM1 (0.50)
SCHEMBL3440790 0.90 DNM1 (0.50)
SCHEMBL2180094 0.90 DNM1 (0.50)
SCHEMBL16658678 0.90 DNM1 (0.50)
SCHEMBL16658679 0.90 DNM1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113628885-B Electrolyte for solid-liquid mixed electrolytic capacitor and electrolytic capacitor 深圳新宙邦科技股份有限公司 2023-04-18 CN claimed
CN-113628885-A Electrolyte for solid-liquid mixed electrolytic capacitor and electrolytic capacitor 深圳新宙邦科技股份有限公司 2021-11-09 CN claimed
CN-101977924-A Novel c-21-keto lupane derivatives preparation and use thereof VIROCHEM PHARMA INC 2011-02-16 CN claimed
US-20070049594-A1 Novel compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2007-03-01 US claimed
EP-1383748-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-01-28 EP claimed
WO-2002051983-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-07-04 WO claimed
US-5707982-A ANTITUMOR ROUSSEL UCLAF (FR) 1998-01-13 US claimed
EP-0687263-B1 PROCESS FOR PREPARING (TRANS)-6- [2-(SUBSTITUTED-PYRROL-1-YL)ALKYL]PYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS WARNER LAMBERT CO (US) 1997-07-30 EP claimed
EP-0687263-A1 NOVEL PROCESS FOR -i(TRANS)-6- 2-(SUBSTITUTED-PYRROL-1-YL)ALKYL]PYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS WARNER LAMBERT CO (US) 1995-12-20 EP claimed
WO-1994020492-A1 NOVEL PROCESS FOR TRANS-6-[2-(SUBSTITUTED-PYRROL-1-YL)ALKYL]PYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS WARNER-LAMBERT COMPANY (US) 1994-09-15 WO claimed
EP-4697957-A1 COMPOSITION COMPRISING AN ANTIMICROBIAL AGENT AND AN ALKOXYLATED AMINE BASF SE (DE) 2026-02-25 EP disclosed
US-20250197353-A1 METHOD OF FORMING BOND BY COUPLING REACTION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-06-19 US disclosed
WO-2024218124-A1 COMPOSITION COMPRISING AN ANTIMICROBIAL AGENT AND AN ALKOXYLATED AMINE BASF SE (DE) 2024-10-24 WO disclosed
EP-4410775-A1 METHOD FOR FORMING BOND THROUGH COUPLING REACTION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-07 EP disclosed
CN-118043308-A Bond formation method based on coupling reaction 中外制药株式会社 2024-05-14 CN disclosed
CN-1106396-A Intermediate compounds for the preparation of aromatic amino alcohol derivatives having anti-diabetic and anti-obesity properties SANKYO CO (JP) 1995-08-09 CN disclosed
WO-1994020492-A1 NOVEL PROCESS FOR TRANS-6-[2-(SUBSTITUTED-PYRROL-1-YL)ALKYL]PYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS WARNER-LAMBERT COMPANY (US) 1994-09-15 WO disclosed
US-5306725-A Mixed solvent of glycol-type compound and amide-type compound KATAYAMA CHEMICAL INC. (JP) 1994-04-26 US disclosed
EP-0569592-A1 CARBOSTYRIL DERIVATIVE AND PLATELET AGGLUTINATION INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-11-18 EP disclosed
EP-0546409-A1 Method for the preparation of tetrahydropyrancarboxylic esters BASF Aktiengesellschaft (DE) 1993-06-16 EP disclosed